Why the study?
Does TAVI improve outcomes compared to medical treatment in high-risk patients with low-flow, low-gradient aortic stenosis?
Does TAVI improve outcomes compared to medical treatment in high-risk patients with low-flow, low-gradient aortic stenosis?
Despite higher early mortality risks, TAVI provides functional and quality of life benefits for long-term survivors with high-risk low-flow, low-gradient aortic stenosis, offering an alternative to medical treatment.
Answers are grounded in this paper and cite their sources.
Despite early mortality risks, TAVI was associated with QoL gains in survivors; hypothesis-generating and should not yet change practice in low-flow low-gradient AS.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lauten et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: